The Journal
Written by: ACRE | Published On: July 17, 2026
Under Eye Polynucleotide Treatments: Commonly Used Options, Protocols and Clinical Considerations
The under-eye area is often one of the earliest parts of the face to show visible signs of ageing. As skin naturally changes over time, patients may notice fine lines, crepiness, dehydration or a tired appearance that can be difficult to address with skincare alone.
In response to growing interest in regenerative aesthetics, many healthcare professionals are incorporating polynucleotide treatments into their treatment portfolios as part of personalised skin rejuvenation plans. Rather than focusing on adding volume, these injectable treatments are commonly used to support improvements in overall skin quality where clinically appropriate.
With several products available, understanding the differences between formulations, treatment protocols and patient suitability is essential for achieving consistent outcomes and delivering safe, evidence-informed care.
At ACRE, we do more than supply aesthetic products. We partner with clinics as a trusted clinical growth partner, providing pharmacy-backed product supply, next-day delivery, practitioner education, recognised brands and HCP-led support to help you confidently introduce and grow regenerative treatment services.
Why Are Polynucleotides Used Around the Eyes?
The skin around the eyes is thinner and more delicate than elsewhere on the face, making it more susceptible to visible signs of ageing. This area also presents unique clinical challenges, requiring careful product selection and appropriate injection technique.
Polynucleotides are commonly used by practitioners as part of regenerative treatment plans because they are intended to support skin quality rather than provide structural volume.
Subject to patient suitability and practitioner assessment, polynucleotide treatments may form part of a treatment plan for patients presenting with:
- Fine lines around the eyes
- Crepey skin texture
- Mild skin laxity
- Dull or dehydrated skin
- Dark circles associated with changes in skin quality
- General under-eye rejuvenation
Patient assessment remains essential, and treatment should always be tailored to individual clinical needs and expectations.
How Do Polynucleotide Treatments Work?
Polynucleotides are highly purified DNA fragments that are incorporated into regenerative aesthetic treatment protocols.
Although mechanisms differ between products, they are commonly used with the aim of supporting the skin's natural repair processes and improving overall skin quality over time.
Depending on the product selected and individual patient factors, treatment may support improvements in:
- Skin hydration
- Skin texture
- Elasticity
- The appearance of fine lines
- Overall skin quality
Results vary between patients and depend on factors including age, lifestyle, skin condition, treatment protocol and aftercare. Setting realistic expectations through a thorough consultation is an important part of the treatment journey.
Commonly Used Polynucleotide Products
Choosing the right product depends on the patient's concerns, treatment goals and practitioner preference. There is no single product that is suitable for every indication, and practitioners should always follow the manufacturer's Instructions for Use alongside their own clinical judgement.
ACRE supplies a carefully selected portfolio of regenerative injectable products, giving practitioners access to trusted brands supported by product education and ongoing HCP-led guidance.
Every product has its own recommended injection technique, treatment schedule and clinical indications. Appropriate training and familiarity with each product are essential before introducing new treatments into practice.
Whether you're adding your first regenerative injectable or expanding your existing portfolio, ACRE provides reliable pharmacy supply, recognised brands and practical support to help your clinic grow with confidence.
How to Choose the Right Polynucleotide Product
Selecting an appropriate product requires a thorough patient consultation and a personalised treatment plan.
Practitioners will often consider:
- The patient's primary concern
- Skin quality and degree of ageing
- Previous aesthetic treatments
- Treatment objectives
- Product characteristics
- Clinical experience and training
As regenerative aesthetics continues to evolve, staying up to date with product developments and treatment techniques is increasingly important.
Through ACRE, practitioners can access not only leading regenerative brands but also product education and training opportunities designed to support confident clinical decision-making.
Typical Under Eye Treatment Protocol
Treatment protocols vary between manufacturers, but many practitioners follow a structured course of treatment.
A typical approach may include:
- An initial course of 2–4 treatment sessions
- Approximately 2–4 weeks between appointments
- Clinical review following completion of the initial course
- Maintenance treatments where appropriate based on practitioner assessment and patient response
Individual treatment plans should always be based on the manufacturer's recommendations, patient suitability and clinical judgement.
Combining Polynucleotides with Other Treatments
Many practitioners incorporate polynucleotides into wider skin rejuvenation plans where clinically appropriate.
Depending on patient assessment, combination approaches may include:
- Medical-grade skincare
- Microneedling
- Chemical peels
- Energy-based treatments
- Botulinum toxin for separate indications
- Hyaluronic acid-based treatments where clinically appropriate
Treatment sequencing should always be planned carefully, with consideration given to manufacturer guidance and the patient's overall treatment goals.
Patient Assessment and Suitability
Comprehensive consultation is essential before administering any injectable treatment.
Practitioners should assess:
- Medical history
- Current medications
- Previous aesthetic treatments
- Skin condition
- Allergies and contraindications
- Patient expectations
- Informed consent
Not every patient will be suitable for polynucleotide treatment, and contraindications vary between products. Practitioners should always refer to the relevant Instructions for Use before treatment.
Why Training Matters
Successful outcomes depend on more than choosing the right product.
The delicate anatomy of the under-eye region requires sound anatomical knowledge, appropriate injection technique and a thorough understanding of product-specific protocols.
Practitioners introducing regenerative injectable treatments should undertake suitable education before treating patients.
As part of our commitment to supporting clinics beyond product supply, ACRE offers access to product education, training opportunities and HCP-led guidance to help practitioners develop confidence when expanding their regenerative treatment offering.
Why Clinics Choose ACRE
Introducing new treatments requires confidence in both your products and your supplier.
ACRE supports healthcare professionals by providing:
- Pharmacy-backed product supply
- Next-day delivery on eligible UK orders
- Access to trusted regenerative aesthetic brands
- Product education to support informed purchasing decisions
- HCP-led customer support
- Practitioner training opportunities
- Dedicated account management focused on long-term clinic growth
Our aim is to help practitioners spend less time worrying about sourcing products and more time delivering high-quality patient care.
Whether you're placing regular stock orders or launching a new regenerative service, ACRE provides the products, support and education needed to help your clinic succeed.
Growing Your Regenerative Aesthetics Offering
Patient interest in regenerative treatments continues to grow, creating opportunities for clinics looking to diversify their services and meet evolving patient demand.
Expanding into regenerative aesthetics requires more than simply purchasing products. Reliable stock availability, product knowledge, practitioner confidence and ongoing support all contribute to delivering a positive patient experience.
That's why ACRE positions itself as a clinical growth partner rather than simply a distributor.
Alongside trusted brands including Plinest, Pluryal, PolyPhil and Nucleofill, we provide pharmacy-backed sourcing, next-day delivery, educational resources, practitioner training and HCP-led support to help clinics introduce regenerative treatments with confidence.
Whether you're exploring polynucleotides for the first time or looking to strengthen your existing regenerative portfolio, our team is here to support every stage of your clinic's growth.
Why Buy Polynucleotide Products Through ACRE?
Choosing a trusted supplier is an important part of delivering consistent patient care.
With ACRE, practitioners benefit from:
- Trusted pharmacy sourcing
- Access to recognised regenerative brands
- Reliable UK stock availability
- Next-day delivery on eligible orders
- Product education and clinical resources
- Practitioner training opportunities
- HCP-led customer support
- A dedicated account team focused on helping your clinic grow
Our approach goes beyond supplying products. We work alongside healthcare professionals to provide the education, service and support needed to build a successful regenerative aesthetics offering.
Ready to expand your regenerative treatment portfolio? Speak to the ACRE team about opening an account, explore our range of Plinest, Pluryal, PolyPhil and Nucleofill products, or find out more about our training opportunities and HCP-led support.
Frequently Asked Questions
How many polynucleotide treatments are typically recommended for the under-eye area?
Many practitioners recommend an initial course of two to four treatment sessions, although protocols vary depending on the product selected, patient assessment and manufacturer recommendations.
Are results immediate?
Polynucleotide treatments are commonly used as part of regenerative treatment plans where changes in skin quality may develop gradually over time. Individual patient responses will vary.
Can polynucleotides replace dermal fillers?
These treatments have different clinical purposes. Polynucleotides are generally selected to support skin quality, while dermal fillers are primarily used to restore or create volume where clinically appropriate.
Who should administer polynucleotide treatments?
Injectable aesthetic treatments should only be carried out by appropriately qualified healthcare professionals who have received suitable product-specific training and practise within the relevant regulatory and professional frameworks.
Partner with ACRE
As regenerative aesthetics continues to evolve, clinics need more than reliable product supply. They need a partner that can support clinical confidence, business growth and long-term success.
ACRE combines trusted pharmacy sourcing with next-day delivery, recognised regenerative brands, product education, practitioner training and HCP-led support, helping clinics build and expand their regenerative treatment offering with confidence.
Explore ACRE's regenerative aesthetics portfolio, open a trade account or speak with our team today to discover how we can support your clinic with trusted products, education and expert guidance at every stage of your growth.
